Treatment of Bleeding (DBCOND0144394)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05147662	A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood	Antihemophilic factor (recombinant), PEGylated Damoctocog alfa pegol	treatment	3	active_not_recruiting
NCT06222697	A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A	Antihemophilic factor (recombinant), PEGylated Damoctocog alfa pegol	Not Available	Not Available	recruiting